ArticleMicromachines2020
Application of a Microfluidic Gas-to-Liquid Interface for Extraction of Target Amphetamines and Precursors from Air Samples.
Article in Micromachines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interpol Review of Drug Analysis 2019-2022.Forensic science international. Synergy · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The investigation of clandestine laboratories poses serious hazards for first responders, emergency services, investigators and the surrounding public due to the risk of exposure to volatile organic compounds (VOCs) used in the manufacture of illicit substances. A novel gas sampling interface using open microfluidic channels that enables the extraction of VOCs out of the gas phase and into a liquid, where it can be analysed by conventional detection systems, has recently been developed. This paper investigates the efficiency and effectiveness of such a gas-to-liquid (GTL) extraction system for the extraction of amphetamine-type substances (ATS) and their precursors from the vapour phase. The GTL interface was evaluated across a range of different ATS and their precursors (methamphetamine, dimethylamphetamine, N-formylmethamphetamine, benzaldehyde, phenyl-2-propanone, ephedrine and pseudoephedrine) at concentrations ranging between 10 and 32 mg m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.